Abu-Amer Y (2013) NF-κB signaling and bone resorption. Osteoporos Int 24:2377–86

Article  CAS  PubMed  Google Scholar 

Aghebati-Maleki L, Dolati S, Zandi R, Fotouhi A, Ahmadi M, Aghebati A, Nouri M, Kazem Shakouri S, Yousefi M (2019) Prospect of mesenchymal stem cells in therapy of osteoporosis: a review. J Cell Physiol 234(6):8570–8578. https://doi.org/10.1002/jcp.27833

Article  CAS  PubMed  Google Scholar 

Ai Z, Wu Y, Yu M, Li J, Li S (2020) Theaflavin-3, 3’-digallate suppresses RANKL-Induced osteoclastogenesis and attenuates ovariectomy-induced bone loss in mice. Front Pharmacol 11:803. https://doi.org/10.3389/fphar.2020.00803

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alfawaz HA, Wani K, Alnaami AM, Al-Saleh Y, Aljohani NJ, Al-Attas OS, Alokail MS, Kumar S, Al-Daghri NM (2018) Effects of different dietary and lifestyle modification therapies on metabolic syndrome in prediabetic arab patients: a 12-month longitudinal study. Nutrients 10(3):383. https://doi.org/10.3390/nu10030383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almeida M, Han LI, Martin-Millan M, Plotkin LI, Stewart SA, Roberson PK, Kousteni S, O’Brien CA, Bellido T, Parfitt AM, Weinstein RS (2007) Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem 282(37):27285–97

Article  CAS  PubMed  Google Scholar 

Almeida M, Iyer S, Martin-Millan M, Bartell SM, Han L, Ambrogini E, Onal M, Xiong J, Weinstein RS, Jilka RL, O’Brien CA (2012) Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual. J Clin Invest 123(1):394–404

Article  PubMed  PubMed Central  Google Scholar 

Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA, Bouillon R, Vanderschueren D, Manolagas SC (2017) Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev 97(1):135–187. https://doi.org/10.1152/physrev.00033.2015

Article  PubMed  Google Scholar 

Armstrong VJ, Muzylak M, Sunters A, Zaman G, Saxon LK, Price JS, Lanyon LE (2007) Wnt/β-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor α. J Biol Chem 282(28):20715–27

Article  CAS  PubMed  Google Scholar 

Arora H, Shang N, Bhullar KS, Wu J (2020) Pea protein-derived tripeptide LRW shows osteoblastic activity on MC3T3-E1 cells via the activation of the Akt/Runx2 pathway. Food Funct 11(8):7197–7207. https://doi.org/10.1039/d0fo00497a

Article  CAS  PubMed  Google Scholar 

Aspray TJ, Hill TR (2019) Osteoporosis and the ageing skeleton. Subcell Biochem 91:453–476. https://doi.org/10.1007/978-981-13-3681-2_16

Article  CAS  PubMed  Google Scholar 

Bado I, Gugala Z, Fuqua SA, Zhang XH (2017) Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis. Oncogene 36(32):4527–37

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bandeira F, de Oliveira LB, Bilezikian JP (2022) Long-term consequences of osteoporosis therapy with denosumab. Arch Endocrinol Metab 66(5):717–723. https://doi.org/10.20945/2359-3997000000560

Article  PubMed  PubMed Central  Google Scholar 

Barron RL, Oster G, Grauer A, Crittenden DB, Weycker D (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31(11):2103–2111. https://doi.org/10.1007/s00198-020-05294-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E (1999) The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 104(6):795–804

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beier EE, Sheu TJ, Resseguie EA, Takahata M, Awad HA, Cory-Slechta DA, Puzas JE (2017) Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice. Bone Res 5:17013. https://doi.org/10.1038/boneres.2017.13

Article  CAS  PubMed  PubMed Central  Google Scholar 

Björnsdottir S, Sääf M, Bensing S, Kämpe O, Michaelsson K, Ludvigsson JF (2011) Risk of hip fracture in Addison’s disease: a population-based cohort study. Intern Med 270(2):187–95

Google Scholar 

Black DM, Rosen CJ (2016) Clinical practice postmenopausal osteoporosis. N Engl J Med 374(3):254–62. https://doi.org/10.1056/NEJMcp1513724

Article  CAS  PubMed  Google Scholar 

Bonewald LF (2007) Osteocyte messages from a bony tomb. Cell Metab 5(6):410–1

Article  CAS  PubMed  Google Scholar 

Brown JP (2021) Long-term treatment of postmenopausal osteoporosis. Endocrinol Metab 36(3):544–552. https://doi.org/10.3803/EnM.2021.301

Article  CAS  Google Scholar 

Brown JP, Engelke K, Keaveny TM, Chines A, Chapurlat R, Foldes AJ, Nogues X, Civitelli R, De Villiers T, Massari F, Zerbini CAF, Wang Z, Oates MK, Recknor C, Libanati C (2021) Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the active-controlled fracture study in postmenopausal women with osteoporosis at high risk (ARCH) trial. J Bone Miner Res 36(11):2139–2152. https://doi.org/10.1002/jbmr.4409

Article  CAS  PubMed  Google Scholar 

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–75

Article  PubMed  Google Scholar 

Burgers TA, Williams BO (2013) Regulation of Wnt/β-catenin signaling within and from osteocytes. Bone 54(2):244–9. https://doi.org/10.1016/j.bone.2013.02.022

Article  CAS  PubMed  PubMed Central  Google Scholar 

Busada JT, Cidlowski JA (2017) Mechanisms of glucocorticoid action during development. Curr Top Dev Biol 125:147–170. https://doi.org/10.1016/bs.ctdb.2016.12.004

Article  CAS  PubMed  Google Scholar 

Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46. https://doi.org/10.4158/GL-2020-0524SUPPL

Article  PubMed  Google Scholar 

Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18(10):1319–28. https://doi.org/10.1007/s00198-007-0394-0

Article  CAS  PubMed  Google Scholar 

Capozzi A, Scambia G, Lello S (2020) Calcium, vitamin D, vitamin K2, and magnesium supplementation and skeletal health. Maturitas 140:55–63. https://doi.org/10.1016/j.maturitas.2020.05.020

Article  CAS  PubMed  Google Scholar 

Chandra A, Rajawat J (2021) Skeletal aging and osteoporosis: mechanisms and therapeutics. Int J Mol Sci 22(7):3553. https://doi.org/10.3390/ijms22073553

Article  CAS  PubMed  PubMed Central  Google Scholar 

Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL (2007) Effect of blockade of TNF-α and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22(5):724–9

Article  CAS  PubMed  Google Scholar 

Chen Z, Xue J, Shen T, Ba G, Yu D, Fu Q (2016) Curcumin alleviates glucocorticoid-induced osteoporosis by protecting osteoblasts from apoptosis in vivo and in vitro. Clin Exp Pharmacol Physiol 43(2):268–76. https://doi.org/10.1111/1440-1681.12513